Regenerative Medical Technology Group Inc
OTC:RMTG
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| US |
|
Regenerative Medical Technology Group Inc
OTC:RMTG
|
526.6k USD |
Loading...
|
|
| CH |
|
Avolta AG
SIX:AVOL
|
7.1B CHF |
Loading...
|
|
| IN |
L
|
Lenskart Solutions Ltd
NSE:LENSKART
|
775.5B INR |
Loading...
|
|
| DE |
F
|
Fielmann Group AG
XMUN:FIE
|
3.5B EUR |
Loading...
|
|
| IN |
B
|
Brainbees Solutions Ltd
NSE:FIRSTCRY
|
130.2B INR |
Loading...
|
|
| ID |
|
MAP Aktif Adiperkasa Tbk PT
IDX:MAPA
|
20T IDR |
Loading...
|
|
| IN |
|
Thangamayil Jewellery Ltd
BSE:533158
|
93.3B INR |
Loading...
|
|
| IN |
|
P N Gadgil Jewellers Ltd
NSE:PNGJL
|
74.6B INR |
Loading...
|
|
| SE |
H
|
Haypp Group AB (publ)
STO:HAYPP
|
3.6B SEK |
Loading...
|
|
| JP |
|
Intermestic Inc
TSE:262A
|
58.9B JPY |
Loading...
|
|
| HK |
|
Eternal Beauty Holdings Ltd
HKEX:6883
|
2.8B HKD |
Loading...
|
Market Distribution
| Min | -4 418 600% |
| 30th Percentile | -9.6% |
| Median | 3.1% |
| 70th Percentile | 11.3% |
| Max | 1 135 400% |
Other Profitability Ratios
Regenerative Medical Technology Group Inc
Glance View
Meso Numismatics, Inc. engages in the provision of regenerative stem cell therapy. The company is headquartered in Boca Raton, Florida. The company went IPO on 2001-12-28. The firm through its subsidiary, Global Stem Cells Group (GSGC), the Company specializes in manufacturing clinical products, cutting edge stem cell research, patient applications, and physical training. The company is engaged in regenerative medicine global research, clinical applications, world class products, lab and clinic equipment, and physician training. Its services include certified training courses for physicians, manufacturing and sales of equipment and supplies, research and development of clinical protocols, regenerative medicine clinics for patients, regenerative medicine practitioners’ network, and turnkey stem cell processing center solutions. The firm with ISSCA (International Society for Stem Cell Application) provides comprehensive physician training and certification programs that medical professionals are equipped with the latest advancements and techniques.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Regenerative Medical Technology Group Inc is -70.1%, which is above its 3-year median of -277%.
Over the last 3 years, Regenerative Medical Technology Group Inc’s Net Margin has increased from -1 370.1% to -70.1%. During this period, it reached a low of -1 370.1% on Jun 30, 2022 and a high of -70.1% on Jun 30, 2025.
